Mr. Dallas intends to stay on as a company director and run for that position again next year, according to an Aug. 1 news release.
“We are very grateful to James Dallas for guiding the Centene Board of Directors through a significant evolution of the company’s governance structure over the course of 2022,” CEO Sarah London said.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
